Clinical Trial Update: Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients [Phase 4]

View source ↗

Summary

Clinical trial evaluating the combination of everolimus and low-dose tacrolimus in kidney transplant recipients (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant
• Renal Allograft Rejection

Drugs mentioned

• Afinitor (everolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Kidney; Complications, Allograft | Phase 4 | Status: UNKNOWN